By immunoelectron microscopy and counterimmuno- electrophoresis, reacts with experimental animal and human antibody for types A and B viral hepatitis, including rhesus, chimpanzee, and human aby for HBV Ags NHB & HB core.
Biosafety Level
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Isolation
Icteric-phase serum (HBsAg+) from patient with viral hepatitis
Product Format
frozen
Storage Conditions
-60°C or colder
Disclosure
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC.
Comments
By immunoelectron microscopy and counterimmuno- electrophoresis, reacts with experimental animal and human antibody for types A and B viral hepatitis, including rhesus, chimpanzee, and human aby for HBV Ags NHB & HB core.
Effect on Host
Lytic CPE on AGMkK TC
Recommended Host
African green monkey kidney cells; human embryonic kidney cells (no CPE)
Icteric-phase serum (HBsAg+) from patient with viral hepatitis
References
Shaw ED. Method of detecting hepatitis B core antigen and antibody. US Patent 4,100,267 dated Jul 11 1978
Shaw ED, et al. Induction of hepatitis B antibody in experimental animals by immunization with A-2 plaque virus. J. Virol. 12: 1598-1607, 1973. PubMed: 4128387
